Status:
UNKNOWN
Prevention of Gestational Diabetes Mellitus With Lifestyle Intervention Among Women of Advanced Maternal Age.
Lead Sponsor:
Peking University
Collaborating Sponsors:
Peking University First Hospital
Conditions:
Gestational Diabetes Mellitus
Eligibility:
FEMALE
35+ years
Phase:
NA
Brief Summary
This is a single-blind randomized controlled trial, aiming to evaluate the preventive effects of mobile-based combining with hospital-based lifestyle interventions on GDM among women with advanced mat...
Detailed Description
After the adjustment of fertility policy in China, the prevalence of advanced maternal age (AMA) has become a crucial issue in maternal health care. AMA can greatly increase the risk of gestational di...
Eligibility Criteria
Inclusion
- local resident in Beijing
- Singleton pregnancy
- Aged ≥35 years
- Overweight or obesity (Body mass index is between 24 and 27.9 kg/m2 or ≥28 kg/m2)
- ≤12 weeks of gestation
- written informed consent is obtained
Exclusion
- Diagnosed with type 1 or type 2 diabetes before pregnancy
- Diagnosed with GDM or impaired glucose tolerance at enrollment
- use of medication that influences glucose metabolism currently, such as metformin, etc.
- multiple pregnancy
- current substance abuse
- unable to exercise due to physical disability
- diagnosed severe psychiatric disorder
- Other conditions not suitable for intervention as judged by physicians
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
346 Patients enrolled
Trial Details
Trial ID
NCT05421845
Start Date
July 1 2022
End Date
December 31 2023
Last Update
June 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University First Hospital
Beijing, Beijing Municipality, China